Endpoints News
Breakout Ventures closes $114M fund Read in browser
Endpoints News
Thank you for reading, dupa dupackia!
basic
UPGRADE
M Tue W Th F
10 March, 2026
95% of AI pilots fail to deliver R&D impact
Is your biologics discovery built to maximize the impact of AI?
sponsored by Cradle
presented by Southern Star Research
South­ern Star Re­search ex­pands Asia foot­print through strate­gic in­vest­ment in Ex­pec­to Health Sci­ence
news
BioNTech co-founders to exit company and start a new one
ENDPOINTS NEWS
Breakout Ventures closes $114M fund, with plans for about 20 investments
ENDPOINTS NEWS
What Prasad's exit means for the FDA moving forward
ENDPOINTS NEWS
Endpoints webinars
Mar 24
11:30 am ET
From structure to selectivity: Federated AI for collaborative binding affinity prediction
Rhino Federated Computing
US Pharma and Biotech Summit - May 14, 2026
US biopharma still leads the world in high-risk drug development, but the road from innovation to access has never been harder to predict. Hear from top executives and investors on how they’re navigating what’s next. Join us.
endpoints pharma
Ipsen pulls cancer drug from market over safety risks
ENDPOINTS NEWS
Hims agrees to limit compounding, ending feud with Novo Nordisk
ENDPOINTS NEWS
Incyte becomes third company to receive CRL over issues at Novo Indiana factory
ENDPOINTS NEWS
in case you missed it
1.
Xenon gets Phase 3 win with epilepsy drug, fueling blockbuster hopes for its first launch
ENDPOINTS NEWS
2.
Updated: Roche’s big-hope breast cancer drug fails in crucial first-line trial
ENDPOINTS NEWS
3.
Exclusive: RNA editing startup Tacit Therapeutics launches with $19M for brain diseases
ENDPOINTS NEWS
4.
Bristol Myers says second CELMoD succeeds in Phase 3
ENDPOINTS NEWS
5.
News Briefing
AbbVie, Gubra post obesity data; Regeneron obesity drug succeeds in China
ENDPOINTS NEWS
6.
GSK licenses pill for liver disease itch to Alfasigma for $300M upfront
ENDPOINTS NEWS
7.
FDA Plans to Loosen Testing Rules to Boost Biosimilar Drugs
BLOOMBERG
Reynald Castaneda
.

It's not even the end of the first quarter, and there's already a long list of CEOs who have made plans to exit their companies. Today's BioNTech news follows previous announcements from Bavarian Nordic, Sarepta and Sanofi, among others.

.
Reynald Castaneda
Deputy Editor, Endpoints News
Endpoints News
2029 Becker Drive; Lawrence, Kansas 66047 USA Privacy and deletion: help@endpointsnews.com
web